Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice.
暂无分享,去创建一个
G. Tiegs | G. Sass | H. Guehring | K. Koerber | R. Bang
[1] H. Bergmeyer. Methods of Enzymatic Analysis , 2019 .
[2] T. Papadopoulos,et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. , 2000, The American journal of pathology.
[3] G. Tiegs,et al. Synergism of Pseudomonas aeruginosa exotoxin A with endotoxin, superantigen, or TNF results in TNFR1- and TNFR2-dependent liver toxicity in mice. , 2000, Immunology letters.
[4] Mao-tsun Lin,et al. Staphylococcal Enterotoxin A Acts through Nitric Oxide Synthase Mechanisms in Human Peripheral Blood Mononuclear Cells To Stimulate Synthesis of Pyrogenic Cytokines , 2000, Infection and Immunity.
[5] C. García-Monzón,et al. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. , 2000, Journal of hepatology.
[6] G. Tiegs,et al. Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. , 1999, Toxicology.
[7] M. Nagayama,et al. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. , 1999, Transplantation.
[8] Simon C Watkins,et al. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. , 1999, The American journal of physiology.
[9] S. Seki,et al. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis. , 1999, Journal of hepatology.
[10] I. Mcfarlane. Pathogenesis of autoimmune hepatitis. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] T. Billiar,et al. IV. Determinants of nitric oxide protection and toxicity in liver. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[12] M. Wheeler,et al. An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle. , 1999, American journal of physiology. Cell physiology.
[13] H. Mühl,et al. Inducible NO synthase: role in cellular signalling. , 1999, The Journal of experimental biology.
[14] Y. Yamaguchi,et al. Peroxynitrite formation during rat hepatic allograft rejection , 1999, Hepatology.
[15] N. Koide,et al. Role of Nitric Oxide in Lipopolysaccharide-Induced Hepatic Injury in d-Galactosamine-Sensitized Mice as an Experimental Endotoxic Shock Model , 1999, Infection and Immunity.
[16] M. Lohoff,et al. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. , 1998, Journal of immunology.
[17] C. Lowenstein,et al. Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] T. Billiar,et al. Nitric Oxide Prevents IL-1β and IFN-γ-Inducing Factor (IL-18) Release from Macrophages by Inhibiting Caspase-1 (IL-1β-Converting Enzyme) , 1998, The Journal of Immunology.
[19] P. Muriel. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. , 1998, Biochemical pharmacology.
[20] Simon C Watkins,et al. Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[21] T. Billiar,et al. Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. , 1998, Surgery.
[22] T. Billiar,et al. Inducible nitric oxide synthase in the liver: regulation and function. , 1998, Biochemistry. Biokhimiia.
[23] L. Moldawer,et al. Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis , 1998, The Journal of Immunology.
[24] A. Peitzman,et al. Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock , 1998, The Journal of experimental medicine.
[25] Carl Nathan. Inducible nitric oxide synthase: what difference does it make? , 1997, The Journal of clinical investigation.
[26] T. Michel,et al. Nitric oxide synthases: which, where, how, and why? , 1997, The Journal of clinical investigation.
[27] George Kollias,et al. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis , 1997, European journal of immunology.
[28] D. Harrison,et al. Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.
[29] B. Halliwell. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? , 1997, FEBS letters.
[30] Simon C Watkins,et al. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. , 1997, Journal of medicinal chemistry.
[31] F. Fang. Mechanisms of nitric oxide-related antimicrobial activity , 1997 .
[32] F. Fang. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.
[33] Simon C Watkins,et al. Nitric Oxide Protects Cultured Rat Hepatocytes from Tumor Necrosis Factor-α-induced Apoptosis by Inducing Heat Shock Protein 70 Expression* , 1997, The Journal of Biological Chemistry.
[34] J. Vauthey,et al. Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. , 1997, Journal of immunology.
[35] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[36] S. Küsters,et al. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. , 1996, Gastroenterology.
[37] H. Fujiwara,et al. Critical involvement of interferon γ in the pathogenesis of T‐cell activation‐associated hepatitis and regulatory mechanisms of interleukin‐6 for the manifestations of hepatitis , 1996, Hepatology.
[38] M. Leist,et al. Interleukin‐1 and nitric oxide protect against tumor necrosis factor α‐induced liver injury through distinct pathways , 1995, Hepatology.
[39] C. Thiemermann,et al. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase , 1995, British journal of pharmacology.
[40] J. Stamler,et al. Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. , 1995, Gastroenterology.
[41] M. Currie,et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. , 1995, The Journal of clinical investigation.
[42] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[43] S. Endres,et al. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. , 1995, Journal of immunology.
[44] T. Billiar,et al. Cyclic GMP and guanylate cyclase mediate lipopolysaccharide‐induced Kupffer cell tumor necrosis factor‐α synthesis , 1995, Journal of leukocyte biology.
[45] J. Pfeilschifter,et al. Dexamethasone differentially affects interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. , 1994, The Biochemical journal.
[46] M. Currie,et al. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. , 1994, Journal of medicinal chemistry.
[47] E. O’Neill,et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.
[48] B. Ryffel,et al. Interferon gamma receptor deficient mice are resistant to endotoxic shock , 1994, The Journal of experimental medicine.
[49] S. Endres,et al. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. , 1993, Biochemical and biophysical research communications.
[50] A. Nussler,et al. Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.
[51] C. Tannenbaum,et al. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. , 1993, Journal of immunology.
[52] B. Barton,et al. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model , 1993, Infection and immunity.
[53] A. Wendel,et al. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.
[54] T. Billiar,et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. , 1990, Annals of surgery.
[55] C. Galanos,et al. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin , 1986, Infection and immunity.
[56] M J Koziel,et al. Cytokines in Viral Hepatitis , 1999, Seminars in liver disease.
[57] C. Nathan,et al. Nitric oxide and macrophage function. , 1997, Annual review of immunology.
[58] A. Wendel,et al. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors. , 1997, The Journal of pharmacology and experimental therapeutics.
[59] M. Leist,et al. Concanavalin A - induced T-cell - mediated hepatic injury in mice : The role of tumor necrosis factor , 1995 .